FI51101C - Process for the preparation of a pharmacologically active 7-substituted pyridyl-2,2-dimethylchromenol. - Google Patents

Process for the preparation of a pharmacologically active 7-substituted pyridyl-2,2-dimethylchromenol.

Info

Publication number
FI51101C
FI51101C FI681030A FI103068A FI51101C FI 51101 C FI51101 C FI 51101C FI 681030 A FI681030 A FI 681030A FI 103068 A FI103068 A FI 103068A FI 51101 C FI51101 C FI 51101C
Authority
FI
Finland
Prior art keywords
dimethylchromenol
preparation
pharmacologically active
substituted pyridyl
pyridyl
Prior art date
Application number
FI681030A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI51101B (en
Inventor
William Raymond Thompson
Raj Kumar Razdan
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Application granted granted Critical
Publication of FI51101B publication Critical patent/FI51101B/fi
Publication of FI51101C publication Critical patent/FI51101C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI681030A 1967-04-14 1968-04-11 Process for the preparation of a pharmacologically active 7-substituted pyridyl-2,2-dimethylchromenol. FI51101C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63080867A 1967-04-14 1967-04-14

Publications (2)

Publication Number Publication Date
FI51101B FI51101B (en) 1976-06-30
FI51101C true FI51101C (en) 1976-10-11

Family

ID=24528640

Family Applications (1)

Application Number Title Priority Date Filing Date
FI681030A FI51101C (en) 1967-04-14 1968-04-11 Process for the preparation of a pharmacologically active 7-substituted pyridyl-2,2-dimethylchromenol.

Country Status (8)

Country Link
AT (1) AT276395B (en)
CA (1) CA931956A (en)
DK (2) DK126856B (en)
ES (1) ES352696A1 (en)
FI (1) FI51101C (en)
IE (1) IE32014B1 (en)
NO (2) NO128711B (en)
SE (1) SE343300B (en)

Also Published As

Publication number Publication date
CA931956A (en) 1973-08-14
NO132431C (en) 1975-11-12
AT276395B (en) 1969-11-25
ES352696A1 (en) 1969-07-16
SE343300B (en) 1972-03-06
IE32014L (en) 1968-10-14
FI51101B (en) 1976-06-30
DK127121B (en) 1973-09-24
NO128711B (en) 1974-01-02
NO132431B (en) 1975-08-04
IE32014B1 (en) 1973-03-21
DK126856B (en) 1973-08-27

Similar Documents

Publication Publication Date Title
FI49300C (en) Process for the preparation of therapeutically active 1,4-dihydropyridine derivatives.
FI48460C (en) Process for the preparation of pharmacologically active novel amino-dihalophenylethylamines.
FI49299C (en) Process for the preparation of hypotensive 1,4-dihydro-4- (2-trifluoromethylphenyl) pyridines.
FI50707C (en) Process for the preparation of new pharmacologically active hydroxycyclohexylamines.
FI49971C (en) Process for the preparation of microbicide-2-nitrofurfurylidenindanone derivatives.
FI45551C (en) Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.
FI48830C (en) Process for the preparation of pharmacologically active lower alkyl-5,6-di-O-benzyl-D-glucofuranosides optionally substituted on phenyl rings.
FI50977C (en) Process for the preparation of 7-chloro-5-phenyl-1,4-benzodiazepines.
FI51101C (en) Process for the preparation of a pharmacologically active 7-substituted pyridyl-2,2-dimethylchromenol.
FI48576C (en) Process for the preparation of therapeutically active alpha-fluoromalic acid derivatives.
FI50630C (en) Process for the preparation of pharmacologically active 2,3,4,4a-tetrahydro-10H-1,2-oxazino (3,2-b) (1,3) benzoxazin-10-ones.
FI49417C (en) Process for the preparation of pharmacologically active 2,3-dihydro-benz ofuran-2-carboxylic acids.
FI48190C (en) Process for the preparation of therapeutically active 10alpha-methoxy-9,10-dihydroergoline derivatives
FI48842C (en) Process for the preparation of pharmacologically active 6-chloro-1H-2,3-benzoxazine.
FI47576C (en) Process for the preparation of 2-alkylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxides.
FI49038C (en) Analogous process for the preparation of new pharmacologically active 4-phenyl-1H-quinazolin-2-one derivatives.
FI48088C (en) Process for the preparation of 5-phenyl-1H-1,4-benzodiazepine derivatives
FI50879C (en) Process for the preparation of therapeutically active substituted 3-aminoacylamino-thiophenes.
FI46066C (en) Analogous process for the preparation of therapeutically active N, N-dimethylamino-ethyl-14beta-hydroxy-5beta-pregn-20-ene-21-carboxylates.
FI48470C (en) Process for the preparation of 2-amino-2H-1,4-bentsodiazepine derivatives.
FI48459C (en) Process for the preparation of pharmacologically active 5-aminopropylide n-10-methyl-5H-dibenzo [a, d / cycloheptenes.
FI50124C (en) Process for the preparation of pharmacologically active 6-chloro-1H-2,3-benzoxazines.
FI43987C (en) Process for the preparation of pharmacologically active 10-aminoalkyl-dibenz (b, f) azepine derivatives
FI48841C (en) Process for the preparation of pharmacologically active 5-nitro-2-furfurylideneaminooxazolidinones.
FI48469C (en) Process for the preparation of 1,4-benzodiazepine derivatives.